Cantor Fitzgerald Issues Positive Forecast for Hyperliquid Strategies (NASDAQ:PURR) Stock Price

Hyperliquid Strategies (NASDAQ:PURR) had its price objective boosted by Cantor Fitzgerald from $5.00 to $6.00 in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. They currently have an overweight rating on the stock.

Separately, Chardan Capital lifted their target price on shares of Hyperliquid Strategies from $8.15 to $8.45 and gave the company a “buy” rating in a report on Thursday. Two analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of $7.23.

Hyperliquid Strategies Price Performance

Shares of NASDAQ PURR opened at $4.26 on Thursday. Hyperliquid Strategies has a 52-week low of $3.01 and a 52-week high of $5.78.

Hyperliquid Strategies (NASDAQ:PURR) last released its quarterly earnings results on Wednesday, February 11th. The company reported ($7.43) EPS for the quarter.

Hedge Funds Weigh In On Hyperliquid Strategies

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. EHP Funds Inc. acquired a new stake in shares of Hyperliquid Strategies in the fourth quarter valued at about $302,000. HRT Financial LP purchased a new position in Hyperliquid Strategies in the fourth quarter valued at about $856,000. Finally, Jane Street Group LLC purchased a new position in Hyperliquid Strategies in the fourth quarter valued at about $339,000. 9.45% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Hyperliquid Strategies

Here are the key news stories impacting Hyperliquid Strategies this week:

• Positive Sentiment: Cantor Fitzgerald raised its price target to $6.00 and moved to an “overweight” rating, implying roughly ~41% upside from the referenced price; this is a near-term bullish analyst signal. Cantor Fitzgerald upgrade
• Positive Sentiment: Chardan Capital raised its target to $8.45 and reiterated a “buy” rating, signaling a materially higher upside (~98% vs. the referenced level) that could attract buyers if confidence in execution improves. Chardan Capital upgrade
• Neutral Sentiment: Short-interest reports show “0” shares and a 0.0 days-to-cover figure for early February — likely a reporting anomaly or timing issue rather than meaningful short activity; this creates ambiguity rather than a clear market pressure.
• Neutral Sentiment: The company issued a press release with its financial results and management commentary noting it is “encouraged by our early execution” after going public; tone is constructive but must be weighed against the reported loss. PR Newswire release
• Negative Sentiment: Hyperliquid reported quarterly EPS of ($7.43), a sizeable loss that is the most direct negative driver for the stock and likely the primary reason for downward pressure on the share price today. Earnings report

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.